Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02867163 · ClinicalTrials.gov registry record
Tranexamic Acid and Blood Clots in Knee Surgery
A clinical trial of Venous Thrombosis, sponsored by University of New Mexi.
- Completed
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT02867163 is a study of Venous Thrombosis that has completed, run by University of New Mexi. The registered enrollment target is 25 participants, below the 1,122-participant average among 9 other Venous Thrombosis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02867163, a study of Venous Thrombosis, has completed, sponsored by University of New Mexi.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational trial to estimate the incidence of deep vein thrombosis (DVT) in total knee replacement patients who received an intraoperative dose of tranexamic acid.
Conditions Studied
Interventions
- DRUG Tranexamic Acid
Study Locations (1)
New Mexico
- Sandoval Regional Medical Center - Rio Rancho
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2017-05-16 |
| Est. Completion | 2017-11-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02867163
The ClinicalTrials.gov registry entry for NCT02867163 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,122-participant average among 9 other Venous Thrombosis trials with a reported enrollment target (98% lower). The listed sponsor is University of New Mexi, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Venous Thrombosis appearing as the primary indexed condition, and to 1 intervention - of which Tranexamic Acid is the first listed.
NCT02867163 reports 1 study location spanning 1 distinct geographic area - top geographies include New Mexico.
Frequently Asked Questions
What is clinical trial NCT02867163 about?
NCT02867163 is a clinical study titled "Tranexamic Acid and Blood Clots in Knee Surgery". This is an observational trial to estimate the incidence of deep vein thrombosis (DVT) in total knee replacement patients who received an intraoperative dose of tranexamic acid.
What is the current status of trial NCT02867163?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2017-05-16. Estimated completion is 2017-11-08.
What conditions does trial NCT02867163 study?
This clinical trial studies the following conditions: Venous Thrombosis.
What interventions are being tested in trial NCT02867163?
The interventions under investigation include: Tranexamic Acid (DRUG).
Who is sponsoring clinical trial NCT02867163?
This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02867163 being conducted?
This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Thrombosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
JETi Lower Extremity Venous Thrombosis
ACTIVE NOT RECRUITING
-
Registry of AngioJet Use in the Peripheral Vascular System
COMPLETED
-
Peripherally Inserted Central Catheter (PICC) Thrombosis: Reverse Taper Versus Non-tapered Catheters
COMPLETED · NA
-
Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
COMPLETED · Phase 3
-
Nifedipine vs Placebo for Maintenance Tocolysis of Preterm Labor.
COMPLETED · NA
-
Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.